Scientists at Albert Einstein College of Medicine of Yeshiva University and their international collaborators have developed a novel fluorescence microscopy technique that for the first time shows where and when proteins are produced.
WuXi PharmaTech will soon start construction of a new, 145,000-square-foot cGMP facility in Philadelphia for the manufacture of cell therapy products.
New biopart assembly standard promises to automate the design and manufacture of synthetic DNA.
Agreement gives BI access to VTU’s Pichia pastoris expression strains for development and manufacturing of therapeutic proteins.
Facility will support planned JCAR015 trial, additional clinical programs, and the company’s first commercial products.
ASI designs, manufactures and delivers customized single-use systems and equipment for the preparation, processing, storage, and transportation of biopharmaceuticals.
Biochemists demonstrate the power of a protein-refolding technique by "unboiling" egg whites.
Please wait while you are redirected to the right page...